Peer-delivered illness self-management program for college students with serious mental illnesses

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the effectiveness of a peer-delivered illness self-management program called Taking Action for college students experiencing serious mental illnesses such as Major Depressive Disorder, Bipolar Disorder, and Schizophrenia. Participants will be randomly assigned to either the Taking Action program or a control group receiving only informational support. The program consists of five 2.5-hour sessions delivered online, focusing on improving mental health self-management skills and academic outcomes. The study aims to assess the feasibility, acceptability, and clinical benefits of the program through interviews conducted at baseline, post-intervention, and follow-up.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Currently enrolled in a 2- or 4-year postsecondary educational institution in the United States (and are able to present a valid student ID card)
* Experiencing a serious mental illness, as operationalized by either:
* A score of 13 or higher on the K-6 Screening Scale for serious mental illness
* Self-reported psychiatric diagnosis of schizophrenia-spectrum or major affective disorder and self-reported lifetime functional impairment due to experiencing mental health challenges
* 18 years of age or older
* Have consistent access to a computer or smartphone and the Internet for communications
* No prior WRAP or Taking Action education

Exclusion Criteria:

* Expected to graduate or complete their program within 2 semesters
* Unable to provide informed consent

Where it's running

• Temple University
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Study coordinator: Elizabeth Thomas, PhD
• Email: elizabeth.thomas@temple.edu
• Phone: 2152041699

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT

  40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.

  Recruiting Medipol University · Istanbul · NCT07534475

• À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness

  This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.

  Recruiting at 2 sites Centre hospitalier de Ville-Evrard, France · Épinay-sur-Seine, Île-de-France Region and 1 other locations · NCT07316803

• Valbenazine for adults with tardive dyskinesia who remain symptomatic on or after a VMAT2 inhibitor

  This trial will test whether valbenazine reduces involuntary movements in adults with tardive dyskinesia who still have symptoms while taking or after stopping a VMAT2 inhibitor.

  Recruiting at 19 sites Phase 4 Neurocrine Biosciences · Bryant, Arkansas and 18 other locations · NCT07105111

• Enhancing Veteran-Clinician Collaboration in VA Care for Serious Mental Illness

  This study tests a 10-session group program to help Veterans with serious mental illness collaborate better with their clinicians and care teams.

  Recruiting VA Office of Research and Development · San Diego, California and 2 other locations · NCT06898879

• Using brain stimulation to improve thinking skills in people with mental health conditions

  This study is testing if a brain stimulation treatment can help improve thinking skills in people with mental health conditions like depression, bipolar disorder, and ADHD.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT04296604

• Genetic counselling to prevent mental health issues from cannabis use

  This study is trying to see if genetic counselling can help young people aged 12 to 21 understand their risk of mental health issues from cannabis use and make better choices about using it.

  Recruiting Nova Scotia Health Authority · Halifax, Nova Scotia · NCT03601026

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.